Listed

NEUROONE MEDICAL TECHNOLOGIES Corp: Form 10-Q for the period ended Sep 30, 2014

Filed with the SEC on Nov 19, 2014 and accepted by EDGAR at Nov 19, 2014, 16:48 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2014-07-01 to 2014-09-30$139us-gaap:SalesRevenueNet
Revenue9 months2014-01-01 to 2014-09-30$607us-gaap:SalesRevenueNet
Gross profit3 months2014-07-01 to 2014-09-30$139us-gaap:GrossProfit
Gross profit9 months2014-01-01 to 2014-09-30$607us-gaap:GrossProfit
Operating income3 months2014-07-01 to 2014-09-30−$6.1kus-gaap:OperatingIncomeLoss
Operating income9 months2014-01-01 to 2014-09-30−$26.0kus-gaap:OperatingIncomeLoss
Net income3 months2014-07-01 to 2014-09-30−$6.1kus-gaap:NetIncomeLoss
Net income9 months2014-01-01 to 2014-09-30−$26.4kus-gaap:NetIncomeLoss
Diluted EPS3 months2014-07-01 to 2014-09-30$0.00us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS9 months2014-01-01 to 2014-09-30$0.00us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow9 months2014-01-01 to 2014-09-30−$17.1kus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Cash and equivalentsAt period end2014-09-30$599us-gaap:Cash
Current assetsAt period end2014-09-30$599us-gaap:AssetsCurrent
Total assetsAt period end2014-09-30$599us-gaap:Assets
Current liabilitiesAt period end2014-09-30$26.1kus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2014-09-30$26.1kus-gaap:Liabilities
Shareholders' equityAt period end2014-09-30−$25.5kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001144204-14-069667. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.